Casey Tansey Named General Partner at U.S. Venture Partners; Veteran Medical Device Company CEO Brings Significant Experience and Relationships in Medical Technology.
Tansey, 47, joins USVP as a managing member of USVP Management Company LLC and of Presidio Management Group IX, LLC, the general partner of USVP IX, the firm's new $600 million fund. He brings to USVP an attractive combination of entrepreneurial, early-stage medical device and substantial operating experience. Most recently, Tansey was president and CEO of Epicor Medical, a venture capital-backed, Sunnyvale medical device company that developed a minimally invasive treatment for atrial fibrillation and was recently acquired by St. Jude Medical.
Prior to Epicor, Tansey was president and CEO of Heartport Inc., one of the leading developers of minimally invasive cardiac surgery. Heartport, a public company, was acquired by Johnson & Johnson in 2001.
"We are delighted to have Casey bring his hands-on, company-building experience and capabilities in medical devices to our partnership," said Phil Young, a veteran USVP general partner who also joined USVP after a career as a CEO of a venture-backed medical device company. "His operating background, domain expertise and fundamentals-oriented, value-building approach to early stage medical technology opportunities are a great fit with USVP's strategy and proven recipe for helping entrepreneurs build the next generation of market-leading companies."
For nearly 10 years before Heartport, Tansey was with Baxter Edwards' Cardiovascular Division. There he held increasingly responsible positions in sales and sales and marketing of various cardiovascular products, including heart valves, oxygenators and other heart lung bypass and cardiac surgery products used by cardiovascular surgeons. He ultimately became the division's vice president of North American sales. Prior to Baxter Edwards, Casey held sales positions with Ethicon and Nestle.
"Since its founding in 1981, USVP has consistently maintained a strong presence in the medical device and life sciences sectors," said Stu Phillips, a former senior Cisco executive and veteran USVP general partner. "This diversification is a fundamental strength of the firm, and Casey's maturity, leadership, stature and relationships reinforce our long-term commitment to life sciences investing."
Tansey will work most closely with the other USVP partners who specialize in life sciences technologies, including Phil Young, Jonathan Root, M.D., Alan Kaganov, Sc.D., and Casper de Clercq.
Tansey hold a B.S. and M.B.A. from the College of Notre Dame in Belmont, CA, and is married with two daughters.
About U.S. Venture Partners
U.S. Venture Partners (USVP) is a Silicon Valley-based venture capital firm dedicated to helping entrepreneurs build world-class companies that are leaders in their respective industries. USVP focuses on early-stage opportunities in sectors in which partners have the domain expertise, operating experience and relationships to make a meaningful contribution to the success of the enterprise. These sectors include digital communications and networking systems, Internet and commerce infrastructure, semiconductors and optical components, and software for enterprise and technical applications, medical devices and biopharmaceuticals. Since its formation in 1981, USVP has invested in more than 370 companies that have, in aggregate, created about $75 billion in stock market value.
|Printer friendly Cite/link Email Feedback|
|Date:||Apr 29, 2005|
|Previous Article:||S3 Investment Company CEO Hails Largest Product Sale in SINO UJE History; Gauging Systems Order Tops $300,000 in Revenue.|
|Next Article:||EB Games Celebrates Opening of Its New Store Location in the Thornton Town Center.|